下一代可转换纳米药物:彻底改变了癌症药物输送和治疗神经系统
Swapnil Shinde1, Saurabh Shah1, Paras Famta1
1Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India.
Molecular pharmaceutics
|May 3, 2025
概括
可转换纳米医学使用可调节的纳米载体特性来改善癌症治疗. 本综述探讨了加强药物输送的策略,克服瘤微环境 (TME) 向的挑战,以获得更好的结果.
科学领域:
- 纳米医学是一种纳米医学.
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
背景情况:
- 传统的癌症疗法面临着循环不良和瘤向效率低下等挑战.
- 纳米医学通过优化纳米载体特性来为药物输送提供解决方案.
- 现有的纳米载体在短的循环时间和免疫系统封存方面扎.
研究的目的:
- 审查用于癌症治疗的可变纳米医学策略.
- 探索如何调节纳米载体特性 (电荷,形态,表面化学) 提高药物输送.
- 分析可调节特征对药理动力学,生物分布和瘤微环境 (TME) 向的影响.
主要方法:
- 关于可变纳米医学的当前文献的综述.
- 对纳米载体中物理化学性质调制的分析.
- 研究内部和外部刺激激活的策略.
- 对药理动力学和TME向的影响评估.
主要成果:
- 调节纳米载体的几何,电荷和水友性可以减轻输送障碍.
- 可转换的策略显示了改善循环和TME积累的潜力.
- 可调节性质影响药物释放动力学和向的药物输送效率.
结论:
- 控制纳米载体特性调节是先进抗癌纳米医学的关键.
- 可转换纳米医学为克服当前治疗局限性提供了有希望的策略.
- 解决临床翻译挑战对于基于纳米医学的癌症疗法的可行性至关重要.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.1K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
